Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
about
Perspective: ambient air pollution: inflammatory response and effects on the lung's vasculaturePerspectives in Biological Monitoring of Inhaled Nanosized ParticlesToxicity of graphene-family nanoparticles: a general review of the origins and mechanismsCarbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicityVariability in bioreactivity linked to changes in size and zeta potential of diesel exhaust particles in human immune cellsAn in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterialsComparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administrationRat pulmonary responses to inhaled nano-TiO₂: effect of primary particle size and agglomeration stateParticulate matter beyond mass: recent health evidence on the role of fractions, chemical constituents and sources of emissionToward responsible development and effective risk management of nano-enabled products in the U.S. construction industryCytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in ratsInhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetesIn vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokineticsA biological perspective toward the interaction of theranostic nanoparticles with the bloodstream - what needs to be considered?Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study.Elevated particle number concentrations induce immediate changes in heart rate variability: a panel study in individuals with impaired glucose metabolism or diabetesDiscovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats.Toxicological Effects of Caco-2 Cells Following Short-Term and Long-Term Exposure to Ag NanoparticlesNeurotoxic potential of lunar and martian dust: influence on em, proton gradient, active transport, and binding of glutamate in rat brain nerve terminals.Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle sizeAdvanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.Nanosafety research--are we on the right track?Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments.Applicability of avidin protein coated mesoporous silica nanoparticles as drug carriers in the lung.Acute toxicity of silver and carbon nanoaerosols to normal and cystic fibrosis human bronchial epithelial cells.Markers of lipid oxidative damage in the exhaled breath condensate of nano TiO2 production workers.Toxic effects and biodistribution of ultrasmall gold nanoparticles.Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3.Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1.Assessment of an in vitro model of pulmonary barrier to study the translocation of nanoparticles.Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification.Primary genotoxicity in the liver following pulmonary exposure to carbon black nanoparticles in mice.Biokinetics of Nanomaterials: the Role of Biopersistence.Long-term effects of silver nanoparticles in caco-2 cells.Assessment of the developmental toxicity of nanoparticles in an ex vivo 3D model, the murine limb bud culture system.Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials.Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy.Nanosicherheitsforschung - sind wir auf dem richtigen Weg?
P2860
Q26859280-16661EF0-D059-4EC9-A506-1533EB41B42DQ27000730-BFD3ED84-AB2E-4C1D-9DD0-5FBB1BE8CA5FQ28071613-058EBBE9-E6A7-4657-9C4F-43928F36B7ABQ28384562-280849DE-9463-40E3-AC13-CAA59111AC37Q28385757-0FF84CDE-C50D-42B4-BA7D-0E5F5D56F5A3Q28388825-A88D63DE-3D1F-4072-9DB2-2011A82B21B2Q28396482-8F5DB98F-4D64-48C0-B0F1-A35B9E1E7F91Q28396687-891E8DC3-3BDC-423D-8A84-6919C3B0401FQ28660762-31379A9E-7A82-4352-8BBD-90741DA1314FQ28950744-41D22F4F-B907-4EF4-9BD7-E45508720D9CQ29248675-375C7666-3F06-4418-9B9C-8E8A72F02C0EQ33948885-7B8248DD-647E-48F4-91BD-25CA586E81E3Q34463566-500BDBDC-60DB-4940-8303-D6DADBC73109Q35067441-F644C912-5677-47D5-BAD4-C484BDF61053Q35161179-BD163731-C69F-4D67-BFB8-F62055B0C33AQ35232766-8261AE9E-9FC7-4699-B04F-FCFE994753EDQ36739570-54F60B31-F9C4-4159-985E-FCA546126EABQ37050888-6326272E-E059-4D93-867A-8130B0C6743FQ37102183-59501572-FCB9-472E-9E07-EC958B5E7FDAQ37651373-71357FF0-12D0-4B57-A689-475F61A32CF9Q38122657-6646A305-A949-4698-8EE9-CC5D7C085460Q38258828-024D69E5-9A84-4741-A88D-F7B393B27327Q38291341-3BA485D8-D0E7-47FC-A347-9898B571FA41Q38542397-7196D14D-E753-42A2-A71C-DF5878B9F702Q38693287-9A915086-9053-40D3-84A5-75DEBA790009Q38782781-DC343C64-4450-4C88-9D60-358B1125D6ECQ38870826-5174F418-F87F-456D-97F3-25AAE9DA0D43Q39180638-A6B90B86-8A2B-47D2-B23F-FCF330445ECEQ39431975-3FE19656-B126-4C8E-8171-8FDA1A36EF08Q40293855-C160F19B-4986-405E-9FBC-841338064CFCQ40293879-5BC4F4D5-9574-49B3-8821-3B64FF7282F6Q41681519-4E3CFFFA-0A43-4D77-B125-82D88D95BFE7Q43802287-300CC9B3-5D4D-4FA2-B74B-0C2BBE286074Q47165165-BB178067-634A-4A34-976B-60BFA5CC0571Q47745983-F558947C-8047-4D05-989E-F444906ED5E4Q50529469-40E1BDB1-D4B4-43C5-AA3B-2FA28D78195AQ50624258-464CFFF5-A18C-4B81-88EC-87A62F1CE47EQ52638280-27D1A6C5-0193-4FFC-B725-18169FF2C7A8Q54237920-73FAB94A-BF50-4028-9EEA-A82C6A6B0475Q55931657-0C2E7387-9D63-4CA1-BC65-D3DB4355CD1D
P2860
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@ast
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@en
type
label
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@ast
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@en
prefLabel
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@ast
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@en
P2093
P2860
P356
P1476
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles.
@en
P2093
Manuela Semmler-Behnke
Shinji Takenaka
Winfried Möller
Wolfgang G Kreyling
P2860
P304
P356
10.1021/AR300043R
P407
P577
2012-09-17T00:00:00Z